NC
ZBH icon

Nicholas Company’s Zimmer Biomet ZBH Stock Holding History

Nicholas Company’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-325,583
Closed -$37M – 218
2017
Q3 		$37M Sell
325,583
-206
-0.1% -$23.8K 0.82% 48
2017
Q2 		$40.6M Sell
325,789
-36
-0% -$4.27K 0.9% 45
2017
Q1 		$38.6M Sell
325,825
-16,861
-5% -$1.91M 0.88% 45
2016
Q4 		$34.3M Buy
342,686
+35,648
+12% +$3.82M 0.77% 43
2016
Q3 		$38.8M Buy
+307,038
New +$37.9M 0.85% 36

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nicholas Company's ZBH Position: Q4 2017 in Review

Nicholas Company sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 325,583 shares — an estimated $37M sold.

Nicholas Company first reported a position in ZBH in Q3 2016 and held it in 5 quarters. The position peaked at $40.6M in Q2 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

  • Nicholas Company reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
  • Nicholas Company sold 325,583 Zimmer Biomet shares in Q4 2017, an estimated $37M.
  • Nicholas Company first reported a position in Zimmer Biomet in Q3 2016 and held it in 5 quarters.
  • Nicholas Company's Zimmer Biomet position peaked at $40.6M in Q2 2017.
  • 870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Nicholas Company's 13F filing for Q4 2017, filed 14 Feb 2018.